FDA 510(k)
FDA class 1
Substantially Equivalent
🇨🇭 Switzerland
ACCUJECT Injector Set 2.1-1P (LP604590)
K Number: K252540
·
Decision Sep 16, 2025
Classifications
1
FEI Numbers
42
Registration Numbers
42
Same Product Code
62
Applicant Total
6
Review Days
35
Basic Information
- Device Name
- ACCUJECT Injector Set 2.1-1P (LP604590)
- K Number
- K252540
- Device Class
- FDA class 1
- Clearance Type
- Traditional
- Regulation Number
- 886.4300
- Medical Specialty
- Ophthalmic
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Medicel AG
- Date Received
- August 12, 2025
- Decision Date
- September 16, 2025
- Product Code
- MSS
- Advisory Committee
- Ophthalmic
- Review Advisory Committee
- OP
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| MSS | Folders And Injectors, Intraocular Lens (Iol) | FDA class 1 | Ophthalmic |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (MSS), ordered by most recent decision date.
RxSight® Insertion Device
FDA 510(k)
FDA Class 1
·Ophthalmic
EyeGility Inserter for Preloaded enVista IOLs
FDA 510(k)
FDA Class 1
·Ophthalmic
Accuject Refra Injector AR2900
FDA 510(k)
FDA Class 1
·Ophthalmic
RxSight® Insertion Device (63002)
FDA 510(k)
FDA Class 1
·Ophthalmic
RxSight Insertion Device
FDA 510(k)
FDA Class 1
·Ophthalmic
CLAREON MONARCH IV IOL Delivery System
FDA 510(k)
FDA Class 1
·Ophthalmic
Other Clearances by Medicel AG
| K Number | Device Name | ||
|---|---|---|---|
| K231106 | Accuject Refra Injector AR2900 | Sep 19, 2023 | Substantially Equivalent |
| K101134 | VISIAN NANOPOINT 2.0 INJECTOR MODEL LP604430 | Aug 9, 2010 | Substantially Equivalent |
| K092023 | NAVIJECT SUB2-1P, MODEL: LP604430 | Jul 28, 2009 | Substantially Equivalent |
| K070669 | IOL INJECTOR SET | Nov 1, 2007 | Substantially Equivalent |
| K040837 | MULTIJECT INJECTOR AND MICROGLIDE CARTRIDGE | Jun 17, 2004 | Substantially Equivalent |